AADI: Aadi Bioscience, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 56.20
Enterprise Value ($M) 25.66
Book Value ($M) 68.87
Book Value / Share 2.79
Price / Book 0.82
NCAV ($M) 60.48
NCAV / Share 2.45
Price / NCAV 0.93

Profitability (mra)
Return on Invested Capital (ROIC) -0.88
Return on Assets (ROA) -0.44
Return on Equity (ROE) -0.52

Liquidity (mrq)
Quick Ratio 4.54
Current Ratio 4.89

Balance Sheet (mrq) ($M)
Current Assets 77.31
Assets 85.70
Liabilities 16.83
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
10-01 13D/A Desai Neil 8.50 -19.64
09-03 13G EcoR1 Capital, LLC 7.50
08-28 13G BML Investment Partners, L.P. 5.60 -34.41

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 11,030 54,791 20.13
2024-11-21 18,843 195,952 9.62
2024-11-20 20,615 60,935 33.83
2024-11-19 50,558 111,257 45.44

(click for more detail)

Similar Companies
ABEO – Abeona Therapeutics Inc. ABVC – ABVC BioPharma, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.